Urologic Oncology: Seminars and Original Investigations
Volume 24, Issue 5 , Pages 384-390, September 2006

Treatment of intermediate-risk prostate cancer with brachytherapy without supplemental pelvic radiotherapy: A review of the H. Lee Moffitt Cancer Center experience

Presented at the 46th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Atlanta, GA, October 3–7, 2004.

  • Javier F. Torres-Roca, M.D.

      Affiliations

    • Department of Interdisciplinary Oncology, University of South Florida College of Medicine and H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-813-972-8424; fax: +1-813-979-7231.
  • ,
  • Alan B. Cantor, Ph.D.

      Affiliations

    • Department of Interdisciplinary Oncology, University of South Florida College of Medicine and H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
  • ,
  • Sonia Shukla

      Affiliations

    • Department of Interdisciplinary Oncology, University of South Florida College of Medicine and H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
  • ,
  • Michael E. Montejo, B.S.

      Affiliations

    • Department of Interdisciplinary Oncology, University of South Florida College of Medicine and H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
  • ,
  • Jay Friedland, M.D.

      Affiliations

    • Department of Interdisciplinary Oncology, University of South Florida College of Medicine and H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
  • ,
  • John D. Seigne, M.B.

      Affiliations

    • Section of Urology, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA
  • ,
  • Randy Heysek, M.D.

      Affiliations

    • Department of Interdisciplinary Oncology, University of South Florida College of Medicine and H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA
  • ,
  • Julio Pow-Sang, M.D.

      Affiliations

    • Department of Interdisciplinary Oncology, University of South Florida College of Medicine and H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA

Received 27 June 2005; received in revised form 16 December 2005; accepted 22 December 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 J.F.T.-R. is supported by a K08 CA108926-01 award from the NCI.

PII: S1078-1439(06)00007-X

doi:10.1016/j.urolonc.2005.12.003

Urologic Oncology: Seminars and Original Investigations
Volume 24, Issue 5 , Pages 384-390, September 2006